Royce & Associates LP Has $21.63 Million Stake in Envista Holdings Corporation $NVST

Royce & Associates LP raised its position in Envista Holdings Corporation (NYSE:NVST) by 11.6% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 996,147 shares of the company’s stock after purchasing an additional 103,312 shares during the period. Royce & Associates LP owned 0.61% of Envista worth $21,626,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently modified their holdings of NVST. Assetmark Inc. lifted its position in shares of Envista by 1.4% during the 4th quarter. Assetmark Inc. now owns 46,273 shares of the company’s stock valued at $1,005,000 after acquiring an additional 659 shares during the period. Allworth Financial LP lifted its position in shares of Envista by 75.4% during the 4th quarter. Allworth Financial LP now owns 1,805 shares of the company’s stock valued at $39,000 after acquiring an additional 776 shares during the period. GAMMA Investing LLC lifted its position in shares of Envista by 31.3% during the 4th quarter. GAMMA Investing LLC now owns 3,281 shares of the company’s stock valued at $71,000 after acquiring an additional 783 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in shares of Envista by 35.3% during the 3rd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 3,041 shares of the company’s stock valued at $62,000 after acquiring an additional 793 shares during the period. Finally, IFP Advisors Inc lifted its position in shares of Envista by 102.9% during the 4th quarter. IFP Advisors Inc now owns 2,112 shares of the company’s stock valued at $46,000 after acquiring an additional 1,071 shares during the period.

Envista Stock Performance

NVST opened at $23.52 on Wednesday. The company has a current ratio of 2.44, a quick ratio of 2.06 and a debt-to-equity ratio of 0.47. The company’s fifty day moving average price is $25.51 and its two-hundred day moving average price is $24.38. Envista Holdings Corporation has a 1-year low of $17.03 and a 1-year high of $30.42. The company has a market cap of $3.83 billion, a price-to-earnings ratio of 57.37, a PEG ratio of 1.47 and a beta of 0.92.

Envista (NYSE:NVST) last released its quarterly earnings data on Wednesday, May 6th. The company reported $0.36 earnings per share for the quarter, topping the consensus estimate of $0.31 by $0.05. Envista had a net margin of 2.41% and a return on equity of 7.11%. During the same quarter in the prior year, the business earned $0.24 EPS. The business’s quarterly revenue was up 14.4% on a year-over-year basis. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. On average, analysts expect that Envista Holdings Corporation will post 1.43 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research firms recently issued reports on NVST. Robert W. Baird boosted their target price on shares of Envista from $30.00 to $31.00 and gave the company an “outperform” rating in a research report on Thursday, May 7th. Wells Fargo & Company boosted their target price on shares of Envista from $21.00 to $26.00 and gave the company an “equal weight” rating in a research report on Friday, February 6th. Stifel Nicolaus set a $31.00 target price on shares of Envista in a research report on Friday, February 6th. Zacks Research downgraded shares of Envista from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 6th. Finally, Citigroup began coverage on shares of Envista in a research report on Wednesday, April 15th. They set a “neutral” rating and a $29.00 target price on the stock. Six analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $28.83.

Envista Profile

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.